Neutralization of SARS-CoV-2 variants by convalescent and vaccinated serum

We tested human sera from large, demographically balanced cohorts of BNT162b2 vaccine recipients (n=51) and COVID-19 patients (n=44) for neutralizing antibodies against SARS-CoV-2 variants B.1.1.7 and B.1.351. Although the effect is more pronounced in the vaccine cohort, both B.1.1.7 and B.1.351 sho...

Descripción completa

Detalles Bibliográficos
Autores principales: Bates, Timothy A., Leier, Hans C., Lyski, Zoe L., McBride, Savannah K., Coulter, Felicity J., Weinstein, Jules B., Goodman, James R., Lu, Zhengchun, Siegel, Sarah A. R., Sullivan, Peter, Strnad, Matt, Brunton, Amanda E., Lee, David X., Curlin, Marcel E., Messer, William B., Tafesse, Fikadu G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043482/
https://www.ncbi.nlm.nih.gov/pubmed/33851185
http://dx.doi.org/10.1101/2021.04.04.21254881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043482/
https://www.ncbi.nlm.nih.gov/pubmed/33851185
http://dx.doi.org/10.1101/2021.04.04.21254881

Ejemplares similares